These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16449623)

  • 1. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus.
    Petri M; Brodsky R
    JAMA; 2006 Feb; 295(5):559-60. PubMed ID: 16449623
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
    JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus.
    Talaulikar D; Tymms KE; Prosser I; Smith R
    Lupus; 2005; 14(2):159-63. PubMed ID: 15751821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
    Burt RK; Han X; Gozdziak P; Yaung K; Morgan A; Clendenan AM; Henry J; Calvario MA; Datta SK; Helenowski I; Schroeder J
    Bone Marrow Transplant; 2018 Jun; 53(6):692-700. PubMed ID: 29855561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma.
    Lane AA; McAfee SL; Kennedy J; Dube C; Attar EC; Ballen KK; Dey BR; Spitzer TR; Chen YB
    Leuk Lymphoma; 2011 Jul; 52(7):1363-6. PubMed ID: 21612379
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Marmont A; Arnold R; Heipe F; Firestein GS; Carrier E; Hahn B; Barr W; Oyama Y; Snowden J; Kalunian K; Traynor A
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S49-51. PubMed ID: 12931242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus.
    Wulffraat NM; Sanders EA; Kamphuis SS; Rijkers GT; Kuis W; Lilien M; Slaper-Cortenbach IC
    Arthritis Rheum; 2001 Mar; 44(3):728-31. PubMed ID: 11263789
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis.
    Atkins H; Freedman M
    Methods Mol Biol; 2009; 549():231-46. PubMed ID: 19378207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor AE
    Arthritis Res Ther; 2003; 5(5):207-9. PubMed ID: 12932278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.
    Melanson SE; Stevenson K; Kim H; Antin JH; Court MH; Ho VT; Ritz J; Soiffer RJ; Kuo FC; Longtine JA; Jarolim P
    Am J Hematol; 2010 Dec; 85(12):967-71. PubMed ID: 21108329
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.
    Loh Y; Oyama Y; Statkute L; Traynor A; Satkus J; Quigley K; Yaung K; Barr W; Bucha J; Gheorghiade M; Burt RK
    Bone Marrow Transplant; 2007 Jul; 40(1):47-53. PubMed ID: 17483845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study.
    Traynor AE; Schroeder J; Rosa RM; Cheng D; Stefka J; Mujais S; Baker S; Burt RK
    Lancet; 2000 Aug; 356(9231):701-7. PubMed ID: 11085688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
    Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
    Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
    Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
    Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.